- Eat Well, Test Well: Bayer HealthCare and dLife Healthcare Solutions launch diabetes resource
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
- Study: Type 2 diabetes market competition heats up amid disease rate increase
- Patients on Type 2 diabetes drugs may experience dangerously low blood sugar despite lack of disease control, study finds
- Abbott launches Glucerna Advance RTD to provide nutritional benefits for those with diabetes
CLIFFSIDE PARK, N.J. The U.S. Patent and Trademark Office has granted a patent to the privately owned company Pop Test for a means for diabetics to measure their glucose levels without drawing blood, Pop Test said Tuesday.
The company said it is conducting clinical trials on a glucose test that uses saliva to allow Type 1 and Type 2 diabetes patients to monitor blood glucose, and can detect abnormally low and abnormally high blood sugar levels.
The company also is developing tests for cholesterol, stress, drugs and alcohol, and pregnancy.
“The Pop Test device will be a tremendous benefit to the millions of people who are afflicted with diabetes around the world,” Pop Test founder Randi Altschul said. “Consumers will be able to monitor their health condition at home with a simple, affordable and painless self-testing device that uses saliva reliably instead of blood.”